Order Article Reprints

King GG, Baker KK, Coveler AL, Harris WP, Cohen SA, Shankaran V, Zhen DB, Safyan RA, Lee HH, Alidina A, et al. Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers. Cancers. 2025; 17(11):1830. https://doi.org/10.3390/cancers17111830

King, Gentry G., Kelsey K. Baker, Andrew L. Coveler, William P. Harris, Stacey A. Cohen, Veena Shankaran, David B. Zhen, Rachael A. Safyan, Hannah H. Lee, Annie Alidina, and et al. 2025. "Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers" Cancers 17, no. 11: 1830. https://doi.org/10.3390/cancers17111830

King, G. G., Baker, K. K., Coveler, A. L., Harris, W. P., Cohen, S. A., Shankaran, V., Zhen, D. B., Safyan, R. A., Lee, H. H., Alidina, A., Hensel, J., Hibbert, R., Durm, G. A., LaFary, Y. C., Younger, A., Kugel, S., Collisson, E., Konnick, E. Q., Redman, M. W., ... Chiorean, E. G. (2025). Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers. Cancers, 17(11), 1830. https://doi.org/10.3390/cancers17111830